Savyon Diagnostics Ltd. of Ashdod at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair

Savyon Diagnostics Ltd.

3 Habosem Street, 7761003 Ashdod

Telephone +972 8 8562920
Fax +972 8 8523176

Hall map

MEDICA 2017 hall map (Hall 3): stand F09

Fairground map

MEDICA 2017 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.05  Infectious Immunology
  • 03.05.01  Bacteriology - Infectious immunology

Our products

Product category: Bacteriology - Infectious immunology

SavvyCheck™ Vaginal Yeast Test

The Vaginal Yeast Test is a rapid lateral flow-based assay for qualitative detection of Candida antigens in cervical secretion sampled by a swab.

Vulvovaginal candidiasis (VVC) is thought to be one of the most common causes of vaginal symptoms. Approximately, 75% of women will be diagnosed with Candida at least once during their lifetime.  40-50% of them will suffer recurrent infections and 5% are estimated to develop chronic Candidiasis.  Candidiasis is more commonly misdiagnosed than other vaginal infections (trichomonas and bacterial vaginosis).  Symptoms of VVC which include: acute itching, vaginal soreness, irritation, rash on the outer lips of the vagina and genital burning that may increase during urination, are nonspecific.  Clinicians should keep in mind that a broad variety of infectious and noninfectious diseases can cause a similar array of symptoms.  To obtain an accurate diagnosis, a thorough evaluation is necessary.  In women who complain of vaginal symptoms, the standard tests, which should be performed, consist of a vaginal pH measurement, saline and 10% potassium hydroxide microscopy.  Microscopy is the mainstay in the diagnosis of VVC, yet studies show that, in academic settings, microscopy has a sensitivity of at best 50% and thus will miss a substantial percentage of women with symptomatic VVC.  To increase the accuracy of diagnosis, yeast cultures have been advocated by some experts as an adjunctive diagnostic test, but these cultures are expensive and underutilized, and they have the further disadvantage that it may take up to a week to get a positive result. Inaccurate diagnosis of Candidiasis may delay treatment and cause more serious lower genital tract diseases. The Vaginal Yeast Test is a point-of-care test for qualitative detection of Candida cervical secretion swabs within 10-20 minutes. It is an important advance in improving the diagnosis of women with VVC.

More Less

Product category: Bacteriology - Infectious immunology

CoproELISA Cryptosporidium

Cryptosporidiosis is a leading cause of persistent diarrhea in developing and developed countries. Cryptosporidiosis is caused by gastrointestinal infection with the protozoan parasite Cryptosporidium spp. Symptoms of cryptosporidiosis include watery diarrhea, stomach cramps, weight loss, nausea, and fever. This highly pathogenic parasite is transmitted in contaminated water and by the faecal-oral route. Prevalence rates of Cryptosporidiosis in a symptomatic population in developed countries exceed 2-3% and serological surveys indicate that the vast majority in the US has been exposed to this pathogen. In addition, this opportunistic pathogen is also highly prevalent in immuno-compromised patients (e.g., 10-40% in HIV patients).

Diagnosis of cryptosporidiosis is routinely performed by microscopic analysis of stool samples using organic dyes. Because detection of Cryptosporidium can be difficult, patients may be asked to submit several stool samples over several days. DNA amplification techniques such as PCR or RT-PCR have been also reported, however, such tests are not commercially available yet.

Savyon’s CoproELISA Cryptosporidium is a newly introduced ELISA-based test for qualitative detection of cryptosporidial antigens in fecal specimens. Combination of both polyclonal and monoclonal antibodies against oocysts of cryptosporidium spp. yields high accuracy with both fresh and formalin/SAF preserved samples.

More Less

Product category: Bacteriology - Infectious immunology

CoproStrip Giardia

The CoproStrip™ Giardia is a rapid chromatographic immunoassay for the qualitative detection of Giardia antigens in human faeces specimens to aid in the diagnosis of giardiasis.

Giardiasis is a diarrhoeal illness seen throughout the world. It is caused by a flagellate protozoan parasite, Giardia intestinalis, also known as G. lamblia and G. duodenalis. Giardia is a common cause of gastrointestinal disturbance in both high- and low-income countries. The incidence of Giardia is generally higher in low-income countries (e.g. many countries of Africa, Asia, and South and Central America) where access to clean water and basic sanitation is lacking. Nearly all children in this setting will acquire Giardiaat some point in their childhood, and the prevalence of the parasite in young children can be as high as 10%-30%. In areas such as Western Europe and the United States of America, Giardia infection is associated with ingestion of contaminated water, person-to-person spread, recent foreign travel, and recreational swimming. Giardia may be a cause of 2%-5% of cases of diarrhoea in high-income countries.

Savyon’s CoproStrip Giardia is a one-step immunochromatographic test for rapid detection of Giardiasis antigens in fecal specimens. The test utilizes specific antibodies directed against Giardia lamblia. cysts and trophozoite  providing high levels of sensitivity and specificity. Results are obtained within 15 minutes and do not require additional reagents and instrumentation.

More Less

Product category: Bacteriology - Infectious immunology


The SeroELISA™ Chlamydia product line is intended for the determination of IgG, IgA and IgM antibodies to Chlamydia in human serum by an Enzyme-Linked Immunosorbent Asssay (ELISA).

The SeroELISA™ Chlamydia test employs the L2 serovar broadly reacting antigen of C. trachomatis. It will detect C. trachomatis, C. psittaci and C. pneumoniae (TWAR) antibodies. Due to the SeroELISA™ pre-calibrated components and assay procedure, the absorbance at 450nm is indicative of IgG, IgA and IgM titer in patient serum specimens.

The SeroELISA™ Chlamydia product line is ideal for high and low volume laboratories.

More Less

Product category: Bacteriology - Infectious immunology

SeroMP Recombinant

The SeroMP™ Recombinant kit is Savyon Diagnostics’s new assay for the semi-quantitative determination of antibodies to M. pneumoniae recombinant antigens in the IgG and IgA ELISA and a mixture of recombinant and native antigen in the IgM ELISA.  The kit is semi-quantitative utilizing three ready-to-use calibrators.

The SeroMP™ Recombinant presents improved performance parameters in different aspects, which bring to a net result of increasing the difference between sick and healthy populations and between positive and negative results. The kit enables a differential determination of specific IgG, IgA and IgM antibodies, as well as the possibility to adapt the assay for automation.

 The added value of using recombinant antigen:

  • Specificity increased due to substantial reduction of prevalence in healthy population
  • Borderline results are clarified to either positive or negative values
  • Sensitivity is maintained or increased in parallel with increasing specificity

More Less

About us

Company details

Savyon Diagnostics develops, manufactures and markets high quality diagnostic kits and systems for the detection of Infectious Diseases and Genetic Screening for more than 30 years through a worldwide network of over 80 distributors.

Savyon Diagnostics is a member of the Gamida for Life group of companies, based in the Netherlands, which is engaged in Healthcare related operations worldwide.

Savyon Diagnostics tests are based upon various immunological and molecular biology techniques (Micro Arrays, RT-PCR, ELISA, MIF, IPA, Lateral Flow etc.) and also maintains multiple patents related to these products. The company possesses the unique “know how” of producing quality core biologicals including: antigens, antibodies and nucleic acid-based probes, while using cutting edge technology to manufacture the products to the high standards that laboratories and research institutions have come to depend upon.

Savyon Diagnostics is accredited with the highest international quality standards of research, development and manufacture, including ISO 13485. The company’s products are all CE-IVD certified and those products sold in the USA, China, Brazil and Australia are FDA 510(k), CFDA, ANVISA and TGA approved, respectively.

Most of Savyon Diagnostics products are developed by our experienced and skilled R&D team who maintain close relationships with international key opinion leaders and academic institutions. Building on its innovative R&D capabilities, Savyon Diagnostics has recently introduced the novel bench-top microarray system the NanoChip®XL analyzer that enables fully automated high throughput testing of DNA/RNA.

Savyon Diagnostics has recently established an Analytical Services unit. The unit complies with GMP guidelines as required by the International Conference on Harmonization (ICH) for active pharmaceutical ingredients. Glycoanalysis services include:

  • N-link glycan analysis by HPLC
  • O-link glycan analysis by HPLC
  • Profiling and quantitative analysis of sialic acid (NeuAc and NeuGc)
  • Quantitative monosaccharaides analysis
The Analytical Unit complements the wide range of services offered by Savyon to the pharma, biotech, IVD and life sciences community. Other services include assay development, contract manufacturing and logistics, as well as QA and RA consulting.

More Less